Literature DB >> 9809794

Multiple forms of rat stomach histidine decarboxylase may reflect posttranslational activation of the enzyme.

C Dartsch1, D Chen, L Persson.   

Abstract

Histidine decarboxylase (HDC) catalyzes the formation of histamine, which takes part in a variety of physiological processes including gastric acid secretion, neurotransmission and inflammation. While purified rat HDC is a homodimer of approximately 54 kDa subunits, molecular cloning of mammalian HDC has revealed that HDC mRNA encodes a 74 kDa protein. This discrepancy in molecular mass may be due to a posttranslational processing of the primary translated product of rat HDC mRNA. In the present study we demonstrate that full-length rat HDC expressed in Escherichia coli or in an in vitro transcription/translation system is enzymatically inactive, while expression of a C-terminus truncated HDC (reducing the molecular mass to 54 kDa) gave rise to a protein with high enzyme activity in the same expression systems. COS-7 cells expressing truncated HDC displayed high HDC activity, whereas COS-7 cells expressing full-length HDC displayed low activity. Western blot analysis of fetal rat liver and oxyntic mucosa of gastrin-stimulated rats revealed the presence of both full-length HDC (approximately 73 kDa) and a approximately 53 kDa subunit form in addition to an intermediate form of about 63 kDa. The results are in line with the view that rat HDC may be produced as an enzymatically inactive proenzyme which is processed to give rise to the active enzyme.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809794     DOI: 10.1016/s0167-0115(98)00045-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

1.  Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.

Authors:  E Lindström; M Björkqvist; R Håkanson
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma.

Authors:  Heather Francis; Sharon DeMorrow; Julie Venter; Paolo Onori; Mellanie White; Eugenio Gaudio; Taylor Francis; John F Greene; Steve Tran; Cynthia J Meininger; Gianfranco Alpini
Journal:  Gut       Date:  2011-08-26       Impact factor: 23.059

3.  Amino- and carboxy-terminal PEST domains mediate gastrin stabilization of rat L-histidine decarboxylase isoforms.

Authors:  J V Fleming; T C Wang
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

4.  The C-terminus of rat L-histidine decarboxylase specifically inhibits enzymic activity and disrupts pyridoxal phosphate-dependent interactions with L-histidine substrate analogues.

Authors:  John V Fleming; Ignacio Fajardo; Michael R Langlois; Francisca Sánchez-Jiménez; Timothy C Wang
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

5.  Control of gastric acid secretion in somatostatin receptor 2 deficient mice: shift from endocrine/paracrine to neurocrine pathways.

Authors:  Chun-Mei Zhao; Vicente Martinez; Laura Piqueras; Lixin Wang; Yvette Taché; Duan Chen
Journal:  Endocrinology       Date:  2007-11-01       Impact factor: 4.736

6.  Mapping of catalytically important residues in the rat L-histidine decarboxylase enzyme using bioinformatic and site-directed mutagenesis approaches.

Authors:  John V Fleming; Francisca Sánchez-Jiménez; Aurelio A Moya-García; Michael R Langlois; Timothy C Wang
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.